← All stocks

Neurogene Inc.

NGNE Scheduled selling only

CIK 0001404644 #2786 in the set updated 19 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$1.13M

$1.13M on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 17 sales

Net

−$1.13M

$0.00 against sales at will

By person

5 insiders · 17 transactions

78.4×

Rachel McMinn holds 78.4 times base salary in stock. $48.58M of shares against $618.80K in salary for 2025.

Salary from the company's own proxy. The shares are what Rachel McMinn last reported holding, valued at $36.13, the price Common Stock was last bought or sold at on the open market here, on 7 Jul 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Cvijic Christine Mikail

President and CFO

—

$900.02K (12) scheduled

−$900.02K

84,040

0.4200%

$3.04M

+59.0%

Cobb Stuart

Chief Scientific Officer

—

$141.45K (3) scheduled

−$141.45K

30,497

0.1524%

$1.10M

+49.6%

McMinn Rachel

Chief Executive Officer

—

$74.00K (1) scheduled

−$74.00K

1,344,307

6.72%

$48.58M

+7.5%

Jordan Julie

Chief Medical Officer

—

$18.13K (1) scheduled

−$18.13K

12,472

0.0623%

$450.66K

—

Samsara BioCapital GP, LLC entity

10% owner

—

1,717,127

8.58%

$62.05M

+2.9%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Cvijic Christine Mikail

7 Jul 2026

President and CFO

Sold on a plan

4,200

$36.13

$151.76K

Cvijic Christine Mikail

6 Jul 2026

President and CFO

Sold on a plan

600

$36.02

$21.61K

Cvijic Christine Mikail

2 Jul 2026

President and CFO

Sold on a plan

1,530

$35.23

$53.90K

Cvijic Christine Mikail

2 Jul 2026

President and CFO

Sold on a plan

2,531

$34.58

$87.52K

Cvijic Christine Mikail

1 Jul 2026

President and CFO

Sold on a plan

739

$34.06

$25.17K

Cvijic Christine Mikail

6 May 2026

President and CFO

Sold on a plan

4,800

$32.44

$155.69K

Cvijic Christine Mikail

6 May 2026

President and CFO

Sold on a plan

4,800

$30.07

$144.35K

Jordan Julie

26 Mar 2026

Chief Medical Officer

Sold on a plan

828

$21.89

$18.13K

McMinn Rachel

26 Mar 2026

Chief Executive Officer

Sold on a plan

3,352

$22.07

$74.00K

Cvijic Christine Mikail

26 Mar 2026

President and CFO

Sold on a plan

2,558

$21.62

$55.32K

Cvijic Christine Mikail

13 Mar 2026

President and CFO

Sold on a plan

263

$22.02

$5.79K

Cvijic Christine Mikail

13 Mar 2026

President and CFO

Sold on a plan

1,395

$21.25

$29.64K

Cvijic Christine Mikail

13 Mar 2026

President and CFO

Sold on a plan

2,387

$20.42

$48.75K

Cobb Stuart

13 Mar 2026

Chief Scientific Officer

Sold on a plan

148

$22.08

$3.27K

Cobb Stuart

13 Mar 2026

Chief Scientific Officer

Sold on a plan

2,658

$21.34

$56.72K

Cobb Stuart

13 Mar 2026

Chief Scientific Officer

Sold on a plan

3,991

$20.41

$81.46K

Cvijic Christine Mikail

27 Feb 2026

President and CFO

Sold on a plan

4,800

$25.11

$120.53K

Show all 17 transactions →

Neurogene Inc.

By person

Individual transactions

What was left out